Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 31 Mar 2025 |
|---|---|---|
| Research and development | 21M | 11M |
| Selling, general and administrative | 9M | 1M |
| Operating expenses | 30M | 13M |
| Operating income | −30M | −13M |
| Pre-tax income | −27M | −12M |
| Income tax | 0 | 0 |
| Net income | −27M | −12M |
| Earnings per share | −1.32 | −19.79 |
| Earnings per share, diluted | −1.32 | −19.79 |
| Weighted average shares | 23M | 736,933 |
| Weighted average shares, diluted | 23M | 736,933 |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 31 Mar 2025 | 31 Dec 2024 | 31 Dec 2023 |
|---|---|---|---|---|---|
| Cash and equivalents | 168M | 22M | 32M | 53M | 16M |
| Current assets | 397M | 152M | — | 56M | — |
| Property, plant and equipment | 21,000 | 22,000 | — | 0 | — |
| Total assets | 397M | 153M | — | 56M | — |
| Current liabilities | 7M | 9M | — | 5M | — |
| Total liabilities | 7M | 9M | — | 5M | — |
| Equity | 391M | −121M | −61M | −48M | −22M |
| Shares outstanding | 37M | 749,760 | — | 736,933 | — |
| Shares issued | 37M | 749,760 | — | 736,933 | — |
| Metric | 31 Mar 2026 | 31 Mar 2025 |
|---|---|---|
| Operating cash flow | −21M | −13M |
| Share-based compensation | 5M | 213,000 |
| Capital expenditure | 0 | 19,000 |
| Investing cash flow | −101M | −16M |
| Financing cash flow | 269M | 8M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator